Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapse

Cancer Biology and Therapy

Volumn 13, Issue 8, 2012, Pages 695-701

  Mollberg, Nathan M ^a,b   Steinert, Gunnar ^b   Aigner, Maximillian ^b   Hamm, Alexander ^b   Lin, Fang Ju ^a   Elbers, Heike ^b   Reissfelder, Christoph ^b   Weitz, Jürgen ^b   Büchler, Markus W ^b   Koch, Moritz ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Colorectal cancer; Metastasis; Prognosis; RalBP1; Survival

Indexed keywords

MESSENGER RNA; RAL BINDING PROTEIN 1; RAL PROTEIN; UNCLASSIFIED DRUG; ABC TRANSPORTER; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; RALBP1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CELL SURVIVAL; COLON ADENOCARCINOMA; CONTROLLED STUDY; DISEASE FREE INTERVAL; DISEASE SEVERITY; EARLY CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; CANCER STAGING; COLORECTAL TUMOR; GENE EXPRESSION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; GTPASE-ACTIVATING PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECURRENCE; RNA, MESSENGER;

EID: 84929503340     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.13.8.20087     Document Type: Article

References (35)

1. Rossé C, Hatzoglou A, Parrini MC, White MA, Chavrier P, Camonis J. RalB mobilizes the exocyst to drive cell migration. Mol Cell Biol 2006; 26:727-34; PMID:16382162; http://dx.doi.org/10.1128/MCB.26.2.727-34.2006.
2. Oxford G, Owens CR, Titus BJ, Foreman TL, Herlevsen MC, Smith SC, et al. RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res 2005; 65:7111-20; PMID:16103060; http://dx.doi.org/10.1158/0008-5472.CAN-04-1957.
3. Yin J, Pollock C, Tracy K, et al. Activation of the RalGEF/Ral Pathway Promotes Prostate Cancer Metastasis to Bone. Mol Cell Biol 2007.
4. Lim KH, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ, et al. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr Biol 2006; 16:2385-94; PMID:17174914; http://dx.doi.org/ 10.1016/j.cub.2006.10.023.
5. Tchevkina E, Agapova L, Dyakova N, Martinjuk A, Komelkov A, Tatosyan A. The small G-protein RalA stimulates metastasis of transformed cells. Oncogene 2005; 24:329-35; PMID:15467745; http://dx.doi.org/10.1038/sj.onc.1208094.
6. Ward Y, Wang W, Woodhouse E, Linnoila I, Liotta L, Kelly K. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol Cell Biol 2001; 21:5958-69; PMID:11486034; http://dx.doi.org/10.1128/MCB.21.17.5958-69.2001.
7. Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD, et al. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 2005; 7:533-45; PMID:15950903; http://dx.doi. org/10.1016/j.ccr. 2005.04.030.
8. Wu Z, Owens C, Chandra N, Popovic K, Conaway M, Theodorescu D. RalBP1 is necessary for metastasis of human cancer cell lines. Neoplasia 2010; 12:1003-12; PMID:21170262.
9. Awasthi S, Singhal SS, Yadav S, Singhal J, Drake K, Nadkar A, et al. RLIP76 is a major determinant of radiation sensitivity. Cancer Res 2005; 65:6022-8; PMID:16024601; http://dx.doi.org/10.1158/0008-5472.CAN-05-0968.
10. Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int J Cancer 2003; 106:635-46; PMID:12866021; http://dx.doi.org/10.1002/ijc.11260.
11. Awasthi S, Singhal SS, Singhal J, Cheng J, Zimniak P, Awasthi YC. Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76. Int J Oncol 2003; 22:713-20; PMID:12632060.
12. Awasthi S, Singhal SS, Singhal J, Yang Y, Zimniak P, Awasthi YC. Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity. Int J Oncol 2003; 22:721-32; PMID:12632061.
13. Stuckler D, Singhal J, Singhal SS, Yadav S, Awasthi YC, Awasthi S. RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer. Cancer Res 2005; 65:991-8; PMID:15705900.
14. Morinaka K, Koyama S, Nakashima S, Hinoi T, Okawa K, Iwamatsu A, et al. Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis. Oncogene 1999; 18:5915-22; PMID:10557078; http://dx.doi.org/10. 1038/sj.onc.1202974.
15. Nakashima S, Morinaka K, Koyama S, Ikeda M, Kishida M, Okawa K, et al. Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors. EMBO J 1999; 18:3629-42; PMID:10393179; http://dx.doi.org/ 10.1093/emboj/18.13.3629.
16. Jullien-Flores V, Mahé Y, Mirey G, Leprince C, Meunier-Bisceuil B, Sorkin A, et al. RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis. J Cell Sci 2000; 113:2837-44; PMID:10910768.
17. Coon BG, Burgner J, Camonis JH, Aguilar RC. The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion. J Biol Chem 2010; 285:33073-81; PMID:20709745; http://dx.doi.org/10.1074/jbc.M110.124123.
18. Singhal SS, Awasthi YC, Awasthi S. Regression of melanoma in a murine model by RLIP76 depletion. Cancer Res 2006; 66:2354-60; PMID:16489041; http://dx.doi.org/10.1158/0008-5472.CAN-05-3534.
19. Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor PJ, Awasthi YC, et al. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Res 2007; 67:4382-9; PMID:17483352; http://dx.doi.org/10.1158/0008-5472.CAN-06-4124.
20. ABI. User bulletin No. 2ABI prism 7700 Sequence Detection System 1997. Relative quantitation of gene expression.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York 1989; 1.
23. Goldfinger LE, Ptak C, Jeffery ED, Shabanowitz J, Hunt DF, Ginsberg MH. RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration. J Cell Biol 2006; 174:877-88; PMID:16966426; http://dx.doi.org/10.1083/ jcb.200603111.
24. Jullien-Flores V, Dorseuil O, Romero F, Letourneur F, Saragosti S, Berger R, et al. Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/ Rac GTPase-activating protein activity. J Biol Chem 1995; 270:22473-7; PMID:7673236.
25. Rossé C, L'Hoste S, Offner N, Picard A, Camonis JH. RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J Biol Chem 2003; 278:30597-604; PMID:12775724; http://dx.doi.org/10.1074/jbc.M302191200.
26. Singhal SS, Yadav S, Vatsyayan R, Chaudhary P, Borvak J, Singhal J, et al. Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis. Cancer Lett 2009; 283:152-8; PMID:19375851; http://dx.doi.org/10.1016/j.canlet.2009.03.033.
27. Kashatus DF, Lim KH, Brady DC, Pershing NL, Cox AD, Counter CM. RALA and RALBP1 regulate mitochondrial fission at mitosis. Nat Cell Biol 2011; 13:1108-15; PMID:21822277; http://dx.doi.org/10.1038/ncb2310.
28. Awasthi S, Singhal SS, Singhal J, Cheng J, Zimniak P, Awasthi YC. Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76. Int J Oncol 2003; 22:713-20; PMID:12632060.
29. Stuckler D, Singhal J, Singhal SS, Yadav S, Awasthi YC, Awasthi S. RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer. Cancer Res 2005; 65:991-8; PMID:15705900.
30. Awasthi S, Singhal SS, Srivastava SK, Zimniak P, Bajpai KK, Saxena M, et al. Adenosine triphosphate-dependent transport of doxorubicin, daunomycin and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. J Clin Invest 1994; 93:958-65; PMID:7907606; http://dx.doi.org/10.1172/JCI117102.
31. Singhal SS, Sehrawat A, Sahu M, Singhal P, Vatsyayan R, Rao Lelsani PC, et al. Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer. Int J Cancer 2010; 126:1327-38; PMID:19626587.
32. Awasthi S, Cheng J, Singhal SS, Saini MK, Pandya U, Pikula S, et al. Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry 2000; 39:9327-34; PMID:10924126; http://dx.doi.org/10.1021/bi992964c.
33. Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int J Cancer 2003; 106:635-46; PMID:12866021; http://dx.doi.org/10.1002/ijc.11260.
34. Cheng JZ, Sharma R, Yang Y, Singhal SS, Sharma A, Saini MK, et al. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J Biol Chem 2001; 276:41213-23; PMID:11522795; http://dx.doi. org/10.1074/jbc.M106838200.
35. Panner A, Nakamura JL, Parsa AT, Rodriguez-Viciana P, Berger MS, Stokoe D, et al. mTOR-independent translational control of the extrinsic cell death pathway by RalA. Mol Cell Biol 2006; 26:7345-57; PMID:16894031; http://dx.doi.org/10.1128/MCB.00126-06.